U.S. commits to additional 100M Moderna COVID-19 vaccine doses

By The Science Advisory Board staff writers

February 12, 2021 -- The U.S. government has purchased an additional 100 million doses of Moderna's COVID-19 vaccine.

The U.S. government's order brings the total number of doses committed from Moderna to 300 million, or enough to vaccinate 150 million people under the two-dose regimen.

To date, Moderna has supplied 41 million doses of the vaccine to the U.S. government and more than 22 million Americans have received the vaccine. Moderna remains on track to deliver the first 100 million doses in the first quarter of 2021 and the second order of 100 million doses in the second quarter of 2021.

The company is working with U.S. manufacturing partners and the U.S. Food and Drug Administration on ways to accelerate vaccine delivery with the goal of providing the new order of 100 million doses before the end of July 2021.

Moderna also intends to continue to manufacture the supply of vaccine doses with its U.S.-based manufacturing infrastructure, it noted.

Copyright © 2021 scienceboard.net
To access all The ScienceBoard content create a free account now:

Email Address:  

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

Letter from the Editor Please send me twice-weekly roundups of all the latest life research and industry news.
SAB Announcements Please send me the latest announcements from The Science Advisory Board and their partners.
Spotlight Receive notifications about new content, services, or educational resources designed to help you sharpen your skills and grow professionally.
I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.

Already have an account? Sign in here